• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    2.25 Contact Hour(s)

    Release Date

    Monday, April 20, 2020

    Offline Date

    Thursday, April 20, 2023

    ACPE Expiration Date

    Thursday, April 20, 2023

    Target Audience

    Pharmacist

    Cost

    $0.00

    • Overview

      Our world has dealt with opioids in some way, shape, or form for centuries, yet so many consider our current opioid crisis as the only incidence in the history of mankind. Considering how Heroin was developed and intended to deal with morphine addiction, and how methadone and buprenorphine aim to address heroin (or really any opioid) addition, each pharmacological entity certainly comes with its own pitfalls. We, as a society, still need to remember the psychological aspects of both the core of addiction and the treatment. The first wave of the current opioid crisis observationally involved prescription opioids (whether attained via prescription or illicitly), the second wave involved heroin, the third wave involves fentanyl analogs and other “laced” products with heroin. Along the way, there are numerous other “natural” and “synthetic” opioid substances that are gaining momentum for utilization of any type across the globe. We are healthcare professionals, and, at the very least, should be able to identify any and all opioid substances, but perhaps then also take those into consideration during clinical conversations reviewing for side effects and drug interactions. This discussion is also part of the overall Substances of Abuse Specialty Pharmacist (SASP) certificate training program. So please join us for a dynamic discussion of the most sensationalized substances on our planet: opioids. Unlike opioids, this presentation is sure to open your eyes and possibly even elevate your blood pressure and/or heart rate!

      Handouts

      • Slide Document :   20064H04_2pp.pdf
      • Slide Document :   20064H04_6pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Calculate morphine milligram equivalent daily dosages (MMEs/Day) based on the 2016 CDC Chronic Pain Opioid Guidelines for common prescription opioid medications.
      Identify typical administration and utilization trends of common opioids substances of abuse whether having an outright illegal status or of legal prescription or over-the-counter origin.
      Distinguish between the diverging legal classification and potency of opioids of abuse.
      Recognize that although studies have shown that 75% of heroin utilizers began with prescription opioid medications, correlating studies show the origin and intention of the prescription opioid use is outside a patient and healthcare professional relationship.
    • Activity Type

      Knowledge

      CE Broker

      20-696533

      Universal Activity Number

      Pharmacist 0798-0000-20-064-H04-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).